Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7217318 | 0.73 | ALDH1A1 (0.44) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL27431253 | 0.69 | ALDH1A1 (0.33) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL7225344 | 0.68 | RAB9A (0.47) | ALDH1A1RAB9ASMN1; SMN2NPC1PKM | |
| SCHEMBL7218303 | 0.67 | HPGD (0.41) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL8527767 | 0.64 | KDM4E (0.31) | KDM4EHPGDKMT2A | |
| SCHEMBL7828483 | 0.64 | CD274 (0.39) | CRHR1ALDH1A1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL23708876 | 0.62 | NPC1 (0.39) | RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL7827771 | 0.61 | CD274 (0.37) | CRHR1ALDH1A1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL7217986 | 0.59 | TP53 (0.47) | CRHR1ALDH1A1HPGD | |
| SCHEMBL2493017 | 0.57 | DAO (0.48) | ALDH1A1KDM4EPKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010046975-A1 | Fungicides for the control of take-all disease of plants | MONSANTO COMPANY | 2001-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010046975-A1 | Fungicides for the control of take-all disease of plants | CNPY3, NAT1, CBR3 | CRHR1 2275/4885ALDH1A1 3549/4885RAB9A 2008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.